Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Conditions: Tuberculosis; Latent Tuberculosis Infection Intervention: Diagnostic Test: QuantiFERON-TB Gold (QFT) test Sponsors: Huashan Hospital; Guizhou Center for Disease Control and Prevention Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Effect of integrating traditional care with modern healthcare to improve tuberculosis control programs in Ethiopia: a protocol for a cluster-randomized controlled trial
DiscussionThis cluster-randomized controlled trial study will assess the effectiveness of a strategy that integrates traditional healthcare into the modern healthcare system for the control and prevention of TB in northwest Ethiopia, where nearly 90% of the population seeks care from traditional care systems. This trial will provide information on the effectiveness of traditional and modern healthcare integration to improve TB case detection, early diagnosis, and treatment, as well as reduce the catastrophic costs of TB.Trial registrationClinicalTrials.gov NCT05236452. Registered on July 22, 2022. (Source: Trials)
Source: Trials - September 11, 2023 Category: Research Source Type: clinical trials
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Conditions: Tuberculosis; Latent Tuberculosis Interventions: Drug: Rifampin and Isoniazid; Drug: isoniazid and rifapentine Sponsor: Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Condition: Tuberculosis Intervention: Sponsor: Tongji Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Conditions: Tuberculosis; Latent Tuberculosis Interventions: Drug: Rifampin and Isoniazid; Drug: isoniazid and rifapentine Sponsor: Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
